| 1/3 | US=9 / Urologia Patel LR, Simons JW. GM-CSF gene-transduced prostate cancer vaccines: GVAX. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 329-42. ISBN 978-1-60327-831-7. |
| 2/3 | US=50 / Câncer Ryan CJ. Development in the management of genitourinary malignancies: prostate cancer and renal cell carcinoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 533-44. ISBN 978-1-60327-086-1. DOENCAS MALIGNAS DO APARELHO GENITURINARIO; CANCER DE PROSTATA; CARCINOMA DE CELULAS RENAIS; CASTRACAO-RESISTENTE O CANCER DE PROSTATA; ANDROGENIOS ADRENAIS; IMUNOTERAPIA; FASE II; ABIRATERONA; ATRASENTAN; BEVACIZUMAB; CALCITRIOL; QUIMIOTERAPIA; GVAX; IPILIMUMAB; IXABEPILONA; SATRAPLATIN; SIPULEUCEL-T; VEGF; SUNITINIB; SORAFENIB |
| 3/3 | US=16 / Urologia Jiménez JA, Li X, Gardner TA, Kao C. Biology and imaging: gene therapy for advanced prostate cancer. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 139-63. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; TERAPIA GENICA; CANCER DE PROSTATA AVANCADO; AAV; AD5/35; ADENOVIRUS; GVAX; HSV-TK; TERAPIA VIRAL ONCOLITICO; OSTEOCALCINA; VACINA; HSP; TRAIL |